Related Experiment Video
Updated: Apr 23, 2026

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
Published on: February 14, 2018
Safety and tolerability of high-dose weekly liposomal amphotericin B antifungal prophylaxis
Elizabeth O Hand1, Meenakshi R Ramanathan
1From the *Pharmacotherapy Division, The University of Texas at Austin College of Pharmacy, Austin; †Pharmacotherapy Education and Research Center, Department of Medicine, The University of Texas Health Science Center at San Antonio; ‡University Hospital; and §Pharmacy Department, The Children's Hospital of San Antonio, San Antonio, TX.
Abstract:
Children with hematologic malignancies are at an increased risk of invasive fungal infections and a greater risk has been seen with exposure to building construction. Prophylaxis with high-dose (IV) liposomal amphotericin B (L-AmB) 10 mg/kg once weekly was initiated in our high risk children based on previous pharmacokinetic studies. This treatment regimen was associated with a 26% incidence of adverse infusion reactions.
Related Concept Videos
Antifungal Agents
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
Pharmacokinetics in Pediatric Patients: Drug Excretion

